Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of 3-OHB in T1D and Healthy Controls
NCT04656236Completed
- Sponsor
- Aarhus University
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of 3-hydroxybutyrate in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Aarhus University. Primary endpoint: Differences in lipolysis rate at 3 hours. Started Jan 2021; status: completed.
02
Drugs
3-hydroxybutyrate
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04656236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656236.